Mwanzo300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Bei iliyotangulia
¥ 18.50
Bei za siku
¥ 18.29 - ¥ 18.62
Bei za mwaka
¥ 12.93 - ¥ 34.18
Thamani ya kampuni katika soko
20.42B CNY
Wastani wa hisa zilizouzwa
18.87M
Uwiano wa bei na mapato
40.65
Mgao wa faida
2.07%
Ubadilishanaji wa msingi
SHE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 816.14M | 11.21% |
Matumizi ya uendeshaji wa biashara | 441.56M | 6.14% |
Mapato halisi | 185.76M | -0.46% |
Kiwango cha faida halisi | 22.76 | -10.50% |
Mapato kwa kila hisa | 0.16 | -2.13% |
EBITDA | 348.52M | 22.34% |
Asilimia ya kodi ya mapato | 6.09% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 310.71M | -70.41% |
Jumla ya mali | 14.52B | -1.41% |
Jumla ya dhima | 4.81B | -6.59% |
Jumla ya hisa | 9.71B | — |
hisa zilizosalia | 1.12B | — |
Uwiano wa bei na thamani | 2.13 | — |
Faida inayotokana na mali | 5.17% | — |
Faida inayotokana mtaji | 6.38% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 185.76M | -0.46% |
Pesa kutokana na shughuli | 178.68M | -37.64% |
Pesa kutokana na uwekezaji | -262.60M | -774.60% |
Pesa kutokana na ufadhili | -42.46M | -25,008.80% |
Mabadiliko halisi ya pesa taslimu | -126.53M | -149.37% |
Mtiririko huru wa pesa | -1.95B | -214.48% |
Kuhusu
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Ilianzishwa
8 Sep 1992
Tovuti
Wafanyakazi
1,902
